These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9750358)

  • 21. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K; Nagamune H; Kourai H
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerolysin--a paradigm for membrane insertion of beta-sheet protein toxins?
    Rossjohn J; Feil SC; McKinstry WJ; Tsernoglou D; van der Goot G; Buckley JT; Parker MW
    J Struct Biol; 1998; 121(2):92-100. PubMed ID: 9615432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms protecting host cells against bacterial pore-forming toxins.
    Brito C; Cabanes D; Sarmento Mesquita F; Sousa S
    Cell Mol Life Sci; 2019 Apr; 76(7):1319-1339. PubMed ID: 30591958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adventures of a pore-forming toxin at the target cell surface.
    Abrami L; Fivaz M; van der Goot FG
    Trends Microbiol; 2000 Apr; 8(4):168-72. PubMed ID: 10754575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and assay of RTX family of cytolysins.
    Lobo AL; Welch RA
    Methods Enzymol; 1994; 235():667-78. PubMed ID: 8057935
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
    Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Damage to cell membranes by pore-forming bacterial cytolysins.
    Bhakdi S; Tranum-Jensen J
    Prog Allergy; 1988; 40():1-43. PubMed ID: 2451254
    [No Abstract]   [Full Text] [Related]  

  • 28. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
    Kaneko J; Kamio Y
    Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diversity of receptor recognition in cholesterol-dependent cytolysins.
    Tabata A; Ohkura K; Ohkubo Y; Tomoyasu T; Ohkuni H; Whiley RA; Nagamune H
    Microbiol Immunol; 2014 Mar; 58(3):155-71. PubMed ID: 24401114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins.
    Heuck AP; Moe PC; Johnson BB
    Subcell Biochem; 2010; 51():551-77. PubMed ID: 20213558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological changes in adherent cells induced by Clostridium difficile toxins.
    von Eichel-Streiber C; Warfolomeow I; Knautz D; Sauerborn M; Hadding U
    Biochem Soc Trans; 1991 Nov; 19(4):1154-60. PubMed ID: 1794484
    [No Abstract]   [Full Text] [Related]  

  • 32. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.
    Polekhina G; Giddings KS; Tweten RK; Parker MW
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):600-5. PubMed ID: 15637162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members.
    Bárcena-Uribarri I; Benz R; Winterhalter M; Zakharian E; Balashova N
    Biochim Biophys Acta; 2015 Jul; 1848(7):1536-44. PubMed ID: 25858109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not as simple as just punching a hole.
    Fivaz M; Abrami L; Tsitrin Y; van der Goot FG
    Toxicon; 2001 Nov; 39(11):1637-45. PubMed ID: 11595627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin.
    Bette P; Oksche A; Mauler F; von Eichel-Streiber C; Popoff MR; Habermann E
    Toxicon; 1991; 29(7):877-87. PubMed ID: 1926186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pore-forming Pseudomonas aeruginosa cytotoxin.
    Xiong G; Struckmeier M; Lutz F
    Toxicology; 1994 Feb; 87(1-3):69-83. PubMed ID: 8160189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial toxins: friends or foes?
    Schmitt CK; Meysick KC; O'Brien AD
    Emerg Infect Dis; 1999; 5(2):224-34. PubMed ID: 10221874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial cytotoxins: targeting eukaryotic switches.
    Aktories K; Barbieri JT
    Nat Rev Microbiol; 2005 May; 3(5):397-410. PubMed ID: 15821726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sticholysin II-mediated cytotoxicity involves the activation of regulated intracellular responses that anticipates cell death.
    Soto C; Bergado G; Blanco R; Griñán T; Rodríguez H; Ros U; Pazos F; Lanio ME; Hernández AM; Álvarez C
    Biochimie; 2018 May; 148():18-35. PubMed ID: 29452280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-helical cytolysins: molecular tunnel-boring machines in action.
    Reitz S; Essen LO
    Chembiochem; 2009 Sep; 10(14):2305-7. PubMed ID: 19693763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.